Chip component mounted wiring board
    1.
    发明授权
    Chip component mounted wiring board 有权
    芯片组件安装接线板

    公开(公告)号:US08331101B2

    公开(公告)日:2012-12-11

    申请号:US12693530

    申请日:2010-01-26

    IPC分类号: H05K1/18

    摘要: A wiring board to be used with being mounted on a packaging board includes a chip component surface-mounted on a surface facing the packaging board. The chip component includes terminal electrodes at both end portions of the component body thereof. Each of the terminal electrodes is provided in a form in which a plated film (Sn) formed on the surface of the terminal electrode is separated into two portions, one portion being on the wiring board side, and another portion being on the packaging board side. In one aspect, each of the terminal electrodes of the chip component is separated into a portion on the wiring board side and a portion on the packaging board side, and the plated film (Sn) is formed on a surface of each of the separated portions of each of the terminal electrodes.

    摘要翻译: 用于安装在包装板上的布线板包括表面安装在面向包装板的表面上的芯片部件。 芯片部件包括其部件主体的两端部的端子电极。 每个端子电极以将形成在端子电极的表面上的镀膜(Sn)分成两部分的形式提供,一部分在布线板侧,另一部分在包装板侧 。 一方面,芯片部件的端子电极中的每一个分离成布线板侧的一部分和封装基板一侧的一部分,并且在每个分离部分的表面上形成镀膜(Sn) 的每个端子电极。

    Cephem compound having pyridinium group
    2.
    发明授权
    Cephem compound having pyridinium group 有权
    具有吡啶鎓基的头孢烯化合物

    公开(公告)号:US09242999B2

    公开(公告)日:2016-01-26

    申请号:US14129631

    申请日:2012-06-26

    摘要: The present invention provides a novel compound which has a broad antibacterial spectrum and particularly exhibits a high antibacterial activity on β-lactamase-producing gram-negative bacteria. Specifically provided are: a compound represented by formula (I) wherein the meaning of each symbol is as defined in the description, an amino-group-protected form of a type of the compound which has the amino group on a ring in a position-7 side chain, or a pharmaceutically acceptable salt of the compound or the amino-group-protected form; and a pharmaceutical composition containing the compound, the amino-group-protected form or the pharmaceutically acceptable salt.

    摘要翻译: 本发明提供了具有广谱抗菌谱的新型化合物,特别是对产生β-内酰胺酶的革兰氏阴性细菌表现出高抗菌活性。 具体提供的是:式(I)表示的化合物,其中每个符号的含义如说明书中所定义,具有位置上具有环上的氨基的化合物的类型的氨基保护形式, 7侧链,或化合物的药学上可接受的盐或氨基保护形式; 和含有该化合物,氨基保护形式或药学上可接受的盐的药物组合物。

    Cephem compound having catechol group
    3.
    发明授权
    Cephem compound having catechol group 有权
    具有儿茶酚基的头孢烯化合物

    公开(公告)号:US09145425B2

    公开(公告)日:2015-09-29

    申请号:US13639412

    申请日:2011-04-04

    摘要: This invention provides Cephem compounds having the formula: or an ester, a protected compound at the amino on the ring in the 7-side chain, a pharmaceutically acceptable salt, or a solvate thereof, a pharmaceutical composition thereof, and a method for treating a bacterial infectious disease with the compound, the ester, the protected compound, the salt, or the solvate thereof, wherein the symbols in the formula are defined in the specification. The compounds exhibit potent antimicrobial spectrum against a variety of bacteria including Gram negative bacteria and/or Gram positive bacteria, preferably beta-lactamase producing Gram negative bacteria, more preferably, multi-drug resistant microbials, in particular, Class B type metallo-beta-lactamase producing Gram negative bacteria, and still preferably extended-spectrum beta-lactamase (ESBL) producing bacteria. The compounds most preferably do not exhibit cross-resistance against known Cephem drugs or Carbapenem drugs.

    摘要翻译: 本发明提供具有下式的Cephem化合物:或酯,7-侧链上的环上的氨基上的被保护的化合物,其药学上可接受的盐或溶剂合物,其药物组合物和 化合物,酯,受保护化合物,盐或其溶剂化物的细菌感染性疾病,其中式中的符号在说明书中定义。 该化合物对各种细菌(包括革兰氏阴性细菌和/或革兰氏阳性细菌,优选β-内酰胺酶产生革兰氏阴性细菌,更优选多药耐药性微生物,特别是B类金属β- 产生革兰氏阴性细菌的内酰胺酶,更优选延长的β-内酰胺酶(ESBL)产生细菌。 该化合物最优选不表现出对已知的Cephem药物或碳青霉烯类药物的抗药性。

    CEPHEM COMPOUND HAVING PYRIDINIUM GROUP
    4.
    发明申请
    CEPHEM COMPOUND HAVING PYRIDINIUM GROUP 有权
    具有吡咯烷基的化合物

    公开(公告)号:US20140114060A1

    公开(公告)日:2014-04-24

    申请号:US14129631

    申请日:2012-06-26

    IPC分类号: C07D501/60

    摘要: The present invention provides a novel compound which has a broad antibacterial spectrum and particularly exhibits a high antibacterial activity on β-lactamase-producing gram-negative bacteria. Specifically provided are: a compound represented by formula (I) wherein the meaning of each symbol is as defined in the description, an amino-group-protected form of a type of the compound which has the amino group on a ring in a position-7 side chain, or a pharmaceutically acceptable salt of the compound or the amino-group-protected form; and a pharmaceutical composition containing the compound, the amino-group-protected form or the pharmaceutically acceptable salt.

    摘要翻译: 本发明提供了具有广谱抗菌谱的新型化合物,特别是对产生β-内酰胺酶的革兰氏阴性细菌表现出高抗菌活性。 具体提供的是:式(I)表示的化合物,其中每个符号的含义如说明书中所定义,具有位置上具有环上的氨基的化合物的类型的氨基保护形式, 7侧链,或化合物的药学上可接受的盐或氨基保护形式; 和含有该化合物,氨基保护形式或药学上可接受的盐的药物组合物。

    NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING NOCICEPTIVE PAIN
    5.
    发明申请
    NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING NOCICEPTIVE PAIN 审中-公开
    用于治疗疼痛的新型药物组合物

    公开(公告)号:US20110152268A1

    公开(公告)日:2011-06-23

    申请号:US13061219

    申请日:2009-09-10

    CPC分类号: C07D265/30 A61K31/5375

    摘要: The present invention relates to a pharmaceutical composition for treating nociceptive pain, containing a morpholine derivative or a pharmaceutically acceptable salt thereof, as an active ingredient. The present invention is useful in providing an excellent pharmaceutical composition for treating nociceptive pain. In addition, the present invention is particularly useful in providing a pharmaceutical composition for treating pain accompanying a disease selected from the group consisting of rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, spondylosis deformans, gouty arthritis, juvenile arthritis, scapulohumeral periarthritis, and cervical syndrome, lumbago, lumbago accompanying spondylosis deformans, menalgia, pain and tumentia after inflammation, operation or injury, pain after odontectomy, and cancer pain. In addition, the present invention is particularly useful for alleviating pain in a damaged cartilage region, and is particularly useful for osteoarthritis in which NSAIDs are not effective.

    摘要翻译: 本发明涉及用于治疗伤害性疼痛的药物组合物,其含有吗啉衍生物或其药学上可接受的盐作为活性成分。 本发明可用于提供用于治疗伤害性疼痛的优异药物组合物。 此外,本发明特别可用于提供用于治疗伴随选自以下的疾病的药物组合物:选自类风湿性关节炎,类风湿性脊椎炎,骨关节炎,变形性椎关节强硬症,痛风性关节炎,幼年型关节炎,肩周炎性关节炎和子宫颈综合征, 腰痛,腰痛伴椎关节僵硬,麻痹症,炎症,手术或损伤后疼痛,咽后切除术后的疼痛,以及癌症疼痛。 此外,本发明特别可用于缓解软骨损伤区域的疼痛,特别适用于NSAIDs无效的骨关节炎。

    Online Diagnostic Method and Online Diagnostic System for Geothermal Generation Facility
    6.
    发明申请
    Online Diagnostic Method and Online Diagnostic System for Geothermal Generation Facility 有权
    地热发电设备在线诊断方法及在线诊断系统

    公开(公告)号:US20110144947A1

    公开(公告)日:2011-06-16

    申请号:US13054972

    申请日:2009-10-19

    IPC分类号: G06F15/00

    CPC分类号: F03G7/04 Y02E10/10

    摘要: An online diagnostic system for a geothermal generation facility is discloses that includes: an automatic steam measurement device for measuring a characteristic of steam to be supplied to a steam turbine from a steam-water separator at the geothermal generation facility that outputs analysis data. A monitor•control device controls an operation of the geothermal generation facility while monitoring the geothermal generation facility. A diagnostic device performs at least one of an evaluation of a steam characteristic at the geothermal generation facility, an evaluation of the steam-water separator, and an evaluation of pulsation and confluence of a production well based on the analysis data from the automatic steam measurement device and performance data of the geothermal generation facility from the monitor•control device. An operating status of the geothermal generation facility is diagnosed.

    摘要翻译: 公开了一种用于地热发电设备的在线诊断系统,其包括:自动蒸汽测量装置,用于从输出分析数据的地热发生设备处的蒸汽水分离器测量要供应给蒸汽轮机的蒸汽的特性。 监测•控制装置控制地热发电设施的运行,同时监测地热发电设施。 诊断装置基于来自自动蒸汽测量的分析数据执行对地热发电设备的蒸汽特性的评价,蒸汽水分离器的评价以及生产井的脉动和汇合的评价中的至少一个 控制装置的地热发电设备的设备和性能数据。 诊断地热发电设施的运行状况。

    NOVEL PREVENTIVE AND/OR THERAPEUTIC AGENT FOR DIABETIC NEUROPATHY
    7.
    发明申请
    NOVEL PREVENTIVE AND/OR THERAPEUTIC AGENT FOR DIABETIC NEUROPATHY 审中-公开
    新型预防和/或治疗糖尿病神经病变药物

    公开(公告)号:US20100113451A1

    公开(公告)日:2010-05-06

    申请号:US12530745

    申请日:2008-03-14

    IPC分类号: A61K31/5375 A61P25/00

    CPC分类号: C07D265/30 A61K31/5375

    摘要: The present invention relates to an agent for preventing and/or treating diabetic neuropathy comprising a 2-[(substituted-inden-7-yloxy)methyl]morpholine of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The invention is useful for providing an excellent agent for preventing and/or treating diabetic neuropathy, and particularly useful for providing an agent for preventing and/or treating diabetic motor neuropathy (such as muscle weakness disorder (such as muscle weakness disorder with inability to walk independently)), diabetic sensory neuropathy (such as paresthesia (such as vibration perception abnormality), allodynia, hypoesthesia (such as numbness of extremities or cold sensation), or pain), or diabetic autonomic neuropathy (such as stool abnormality (such as constipation or diarrhea), urination disorder, impotence, orthostatic hypotension, sudomotor dysfunction, abnormal heart rate variability, or delayed gastric emptying). Further, the invention is particularly useful for providing an agent for improving pathophysiology of diabetic neuropathy.

    摘要翻译: 本发明涉及用于预防和/或治疗糖尿病性神经病变的药剂,其包含式(I)的2 - [(取代 - 茚-7-基氧基)甲基]吗啉或其药学上可接受的盐作为活性成分。 本发明可用于提供用于预防和/或治疗糖尿病性神经病变的优异剂,特别可用于提供用于预防和/或治疗糖尿病运动神经病变(如肌肉无力障碍(例如无力行走的肌肉无力障碍) 独立)),糖尿病感觉神经病变(如感觉异常(如振动感知异常),异常性疼痛,麻醉(如四肢麻木或感冒)或疼痛)或糖尿病性自主神经病变(如便秘便秘) 或腹泻),排尿障碍,阳ence,直立性低血压,苏体功能障碍,异常心率变异性或延迟胃排空)。 此外,本发明特别可用于提供改善糖尿病性神经病变病理生理学的药剂。

    Electronic cash register and price calculation method
    8.
    发明授权
    Electronic cash register and price calculation method 失效
    电子收款机和价格计算方法

    公开(公告)号:US06168076A

    公开(公告)日:2001-01-02

    申请号:US09149176

    申请日:1998-09-08

    IPC分类号: G07G100

    摘要: Unit items ordered by a customer are accepted. An automatic selection is given of unit items, from among the accepted unit items, which compose at least one of predetermined set-menu item combinations having respective predetermined discount prices. A price corresponding to a customer's order is calculated in response to the predetermined discount price of the previously-mentioned one of the predetermined set-menu item combinations.

    摘要翻译: 接受客户订购的单位物品。 从所接受的单位项目中给出单元项目的自动选择,其组成具有各自的预定折扣价格的预定设置菜单项目组合中的至少一个。 响应于先前提到的预定设置菜单项组合的预定折扣价格计算与客户订单相对应的价格。